Evaluation of Role of Factor V Leiden Mutation in Fatal Pulmonary Thromboembolism
- 1 July 1998
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 91 (1), 7-14
- https://doi.org/10.1016/s0049-3848(98)00049-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The factor V Leiden mutation: Spectrum of thrombotic events and laboratory evaluationJournal of Vascular Surgery, 1997
- Resistance to activated protein C, the FV : Q 506 allele, and venous thrombosisAnnals of Hematology, 1996
- World distribution of factor V LeidenThe Lancet, 1995
- Molecular Detection of a Common Mutation in Coagulation Factor V Causing Thrombosis via Hereditary Resistance to Activated Protein CDiagnostic Molecular Pathology, 1995
- Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy MenNew England Journal of Medicine, 1995
- Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.Journal of Clinical Investigation, 1994
- High prevalence of a mutation in the factor V gene within the U.K. population: relationship to activated protein C resistance and familial thrombosisBritish Journal of Haematology, 1994
- Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient familiesBlood, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Prevention of Venous Thrombosis and Pulmonary EmbolismPublished by American Medical Association (AMA) ,1986